Ray Dalio acquired 29.8 Thousand Neogenomics shares worth $422 Thousand. That's 0.00% of their equity portfolio (701st largest holding). The first Neogenomics trade was made in Q1 2023. Since then Ray Dalio bought shares one more times and sold shares on two occasions. The investor's estimated purchase price is $428 Thousand, resulting in a loss of 1.3%.